Thomas T Huynh
Overview
Explore the profile of Thomas T Huynh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sultan M, Nearing J, Brown J, Huynh T, Cruickshank B, Lamoureaux E, et al.
Mol Oncol
. 2021 May;
15(8):2046-2064.
PMID: 33932086
Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment...
2.
Huynh T, Sultan M, Vidovic D, Dean C, Cruickshank B, Lee K, et al.
Sci Rep
. 2019 Jul;
9(1):9414.
PMID: 31263158
Acute promyelocytic leukemia (APL) is characterized by arrested differentiation of promyelocytes. Patients treated with all-trans retinoic acid (ATRA) alone experience relapse, while patients treated with ATRA and arsenic trioxide (ATO)...
3.
Vidovic D, Huynh T, Konda P, Dean C, Cruickshank B, Sultan M, et al.
Cell Death Differ
. 2019 Jun;
27(1):363-378.
PMID: 31197235
To discover novel therapeutic targets for triple-negative breast cancer (TNBC) and cancer stem cells (CSCs), we screened long non-coding RNAs (lncRNAs) most enriched in TNBCs for high expression in CSCs...
4.
Sultan M, Vidovic D, Paine A, Huynh T, Coyle K, Thomas M, et al.
Stem Cells
. 2018 Jan;
36(5):641-654.
PMID: 29341428
Avoiding detection and destruction by immune cells is key for tumor initiation and progression. The important role of cancer stem cells (CSCs) in tumor initiation has been well established, yet...